Nutex Health, INC DEF 14A proxy statements

Nutex Health Inc. announced its 2026 Annual Meeting of Stockholders to be held virtually on April 23, 2026, focusing on director re-elections, executive compensation, and auditor ratification.

Nutex Health Inc. announced the filing of a supplement to its definitive proxy statement, urging shareholders to review it in preparation for the upcoming Annual Meeting on July 14, 2025.

Nutex Health Inc. has issued a supplement to its proxy statement, providing additional disclosures on the potential dilutive impact of its proposed equity incentive plan amendment and detailing significant stock-based compensation related to prior hospital mergers.

Nutex Health Inc. has issued a supplement to its proxy statement, clarifying the voting requirements for its 2023 Equity Incentive Plan amendment and confirming agenda items for its July 14, 2025 Annual Meeting, including director re-elections and a new board nominee.

Nutex Health Inc. has announced the internet availability of its definitive proxy materials for its 2025 annual meeting, which will be held virtually on July 14, 2025.

Nutex Health Inc. has announced its 2025 Annual Meeting of Stockholders for July 14, 2025, where shareholders will vote on director elections, executive compensation, and a significant increase in the company's equity incentive plan shares.

Nutex Health Inc. has announced the availability of its definitive proxy materials for its 2024 annual meeting, which will be held virtually on June 17, 2024.

Nutex Health Inc. has scheduled its 2024 Annual Meeting for June 17, 2024, and is providing proxy materials to shareholders for voting on key proposals.

Nutex Health is holding its annual meeting on June 17, 2024, to vote on director re-election, executive compensation, a reverse stock split, and auditor ratification.